InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2026-08-11 16:51:01 ET · period of report 2026-08-10 · accession 0002110603-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-11 16:51 2026-08-10 GILD Cain Wettan Keeley M EVP Gen Counsel, Legal, Comp M - OptEx — +6,002 11.4K +112% —
D 2026-08-11 16:51 2026-08-10 GILD Cain Wettan Keeley M EVP Gen Counsel, Legal, Comp F - Tax $133.06 -2,908 8,454 -26% -$386.9K
D 2026-08-11 16:51 2026-08-10 GILD Cain Wettan Keeley M EVP Gen Counsel, Legal, Comp M - OptEx — -6,002 14.0K -30% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-10 M A 6,002 — 11,362 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2 Common Common Stock 2026-08-10 F D 2,908 $133.06 8,454 D — —
3 Derivative Restricted Stock Unit 2026-08-10 M D 6,002 — 13,995 D — · — to — 6,002 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. (F2) The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.